桑托胡摩尔通过控制无处化调节的 Ets-1 周转率来克服 osimertinib 的耐药性
Ying Ma1,2, Ruirui Wang1, Jinzhuang Liao1
1Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
Cell death discovery
|October 29, 2024
概括
向c-Met克服了非小细胞肺癌 (NSCLC) 中的奥西默提尼布耐药性. 一种天然化合物桑托胡摩尔抑制了c-Met信号传递,使抗性NSCLC细胞对治疗敏感,并提高了生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是一个重大的全球卫生挑战.
- 氨酸激酶抑制剂 (TKI),如奥西默蒂尼布,改善了EGFR突变NSCLC的治疗结果.
- 获得对TKI的耐药性是一个重要的临床障碍,需要新的治疗策略.
研究的目的:
- 为了研究NSCLC中 osimertinib 耐药性的机制.
- 确定新的治疗点和药物来克服TKI耐药性.
- 为了评估与 osimertinib 结合使用的香醇的疗效.
主要方法:
- 在耐奥西默提尼布NSCLC细胞中对c-Met的表达分析.
- 在体外和体内对c-Met耗尽和桑托荷摩尔治疗的疗效研究.
- 对自然产品库进行选,以识别c-Met抑制剂.
- 涉及USP9X,Ets-1和下游信号通路的机制研究.
主要成果:
- 在耐奥西默提尼布的NSCLC细胞中发现了高c-Met表达.
- 在抗药性模型中,c-Met的耗尽抑制了增殖,改善了耐药性模型的生存率.
- 赞索醇显示出强大的抑制作用,并使耐性细胞对 osimertinib 产生敏感性.
- 香醇破坏了USP9X-Ets-1的相互作用,抑制了Ets-1的酸化,并诱导了亡.
结论:
- 准c-Met信号轴对于克服NSCLC中 osimertinib 耐药性至关重要.
- 桑托胡醇显示为增强奥西默提尼布疗效的治疗剂具有前景.
- 这项研究提供了管理TKI耐药NSCLC的新策略.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.9K
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K